Supplemental material
Modern Rheumatology
Volume 31, 2021 - Issue 3
Open access
912
Views
0
CrossRef citations to date
0
Altmetric
Rheumatoid Arthritis
Post-marketing surveillance of high-dose methotrexate (>8 mg/week) in Japanese patients with rheumatoid arthritis: A post hoc sub-analysis of patients according to duration of prior methotrexate use
Yasuo Suzukia Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Tokyo, Japan
, Tomohiro Hiroseb Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan;c Immunology and Inflammation Medical Affairs, Pfizer Innovative Health, Pfizer Japan Inc, Tokyo, JapanCorrespondence[email protected]
, Noriko Sugiyamad Clinical Statistics, Biometrics and Data Management, Pfizer R&D Japan, Tokyo, Japan
, Kazuto Nomurae Post-Marketing Study Strategy and Management, Development Japan, Pfizer R&D Japan, Tokyo, Japan
& Eduardo Campos-Albertoc Immunology and Inflammation Medical Affairs, Pfizer Innovative Health, Pfizer Japan Inc, Tokyo, Japan
Pages 575-586
|
Received 05 Jun 2020, Accepted 07 Sep 2020, Published online: 21 Jan 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.